Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alemtuzumab vs Chlorambucil in Front-Line B-CLL
NCT00046683Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jul 2001
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of alemtuzumab in chronic lymphocytic leukemia (CLL), sponsored by Sanofi. Started Jul 2001; status: completed.
02
Drugs
alemtuzumab
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00046683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00046683.